Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.64
+0.47001.34%
Post-market: 35.640.00000.00%16:10 EDT
Volume:4K
Turnover:146.92K
Market Cap:1.96M
PE:- -
High:35.64
Open:35.10
Low:35.10
Close:35.17
52wk High:36.54
52wk Low:23.88
Shares:55.00K
Float Shares:55.00K
Volume Ratio:2.21
T/O Rate:7.56%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amylyx Phase 3 data support FDA approval, says Citi

TIPRANKS
·
Aug 18

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.
·
Aug 18

Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital

TIPRANKS
·
Aug 18

Steris PLC Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Illumina Completes $300 Million Debt Refinancing Offering

TIPRANKS
·
Aug 18

Illumina Completes $300 Million Notes Offering Due 2029

Reuters
·
Aug 18

Vortex Energy Appoints Market Maker to Boost Liquidity on CSE

TIPRANKS
·
Aug 18

Vertex (VERX) Is Up 6.5% After Q2 Profit, Raised 2026 Outlook And New AI-Focused Hires

Simply Wall St.
·
Aug 17

Steris PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Crinetics nears shareholder vote on Vertex merger

TIPRANKS
·
Aug 14

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

TIPRANKS
·
Aug 14

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Reuters
·
Aug 14

Illumina Secures New Syndicated Credit Facility Agreement

TIPRANKS
·
Aug 14

Illumina - Enters Credit Agreement on August 13, 2026

Reuters
·
Aug 14

Illumina Enters USD 1 Billion Five-Year Revolving Credit Facility with Bank of America-Led Lenders

Reuters
·
Aug 14

Illumina - Credit Agreement Provides for $1 Bln Five-Year Revolving Credit Facility - SEC Filing

THOMSON REUTERS
·
Aug 14

Illumina - Credit Agreement Includes Option to Increase Commitments or Term Loans up to $500 Mln - SEC Filing

THOMSON REUTERS
·
Aug 14

Thermo Fisher EVP Michael D. Shafer Disposes of 25,500 Common Shares Worth $15.3 Million Under 10b5-1 Plan

Reuters
·
Aug 14

Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 13

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

TIPRANKS
·
Aug 13